Panel Discussion at BIO 2022 – Safety Aspects of AAV and Lentivirus-based Cell and Gene Therapy

SIRION Biotech is pleased to host the panel discussion on Safety Aspects of AAV and Lentivirus-based Cell and Gene Therapy at this year’s BIO convention in San Diego. The discussion will take place on Thursday June 16 at 10:15 am.

Panelists are
Dr. Donald Kohn, Professor at UCLA
Dr. Palani Palaniappan, Chief Technology Officer. Flagship Pioneering
Dr. Basel Assaf, Distinguished Scientist, Sanofi.
Dr. Christian Thirion, CEO and Founder, SIRION Biotech